Literature DB >> 9412985

Lack of NK cells in lupus patients with renal involvement.

F M Erkeller-Yuksel1, P M Lydyard, D A Isenberg.   

Abstract

We have previously shown that patients with SLE have significantly lower percentages and absolute numbers of NK(CD3-/CD16+56) cells in their peripheral blood compared with normals. Patients with active disease had very low levels of NK cells and the reduction was also associated with patients who had renal involvement. We have now performed a serial study immunophenotyping 11 patients with SLE and renal involvement using dual colour immunofluorescence and flow cytometry. Patients were tested every three months on an average of three occasions. As a control, nine SLE patients without renal involvement were immunophenotyped for similar intervals; 11 normal controls were also tested. Major lymphocyte subsets (T, B and NK) remained very stable during serial bleeds. However, the NK cell populations were decreased significantly in patients with renal involvement both as percentages (5 +/- 6 vs 9 +/- 5, P < 0.0001) and absolute counts (75 +/- 108 vs 109 +/- 52, P < 0.001) in comparison to non-renal patients. Analysis of disease activity using BILAG score showed an inverse correlation between renal system activity and percentage and absolute number of NK cells (P < 0.002 and 0.01, respectively). In this study we have also analysed a CD8 T cell subset which we have not studied before. We have found a significantly increased percentage of CD38+CD8+ T cells(activated CD8 subset) in patients with SLE in comparison to normal controls. We did not find any association with the CD38+CD8+ T cells and disease activity as measured by BILAG or renal involvement. NK cells are important factors in immunity against virus infections and tumour cells. CD38+CD8+T cells are increased in viral infections. We speculate that the lack of NK cells in SLE patients might have an association with increased CD38 expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9412985     DOI: 10.1177/096120339700600905

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  24 in total

Review 1.  Natural killer cells in human autoimmune diseases.

Authors:  Nicolas Schleinitz; Frédéric Vély; Jean-Robert Harlé; Eric Vivier
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

Review 2.  Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Authors:  Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

3.  NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.

Authors:  Roberto Spada; José M Rojas; Sonia Pérez-Yagüe; Vladimir Mulens; Pablo Cannata-Ortiz; Rafael Bragado; Domingo F Barber
Journal:  J Leukoc Biol       Date:  2015-01-12       Impact factor: 4.962

4.  A subgroup of lupus patients with nephritis, innate T cell activation and low vitamin D is identified by the enhancement of circulating MHC class I-related chain A.

Authors:  M Pérez-Ferro; F I Romero-Bueno; C Serrano Del Castillo; I Mahillo; A Alvear; R Largo; G Herrero-Beaumont; O Sánchez-Pernaute
Journal:  Clin Exp Immunol       Date:  2019-02-27       Impact factor: 4.330

5.  Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection.

Authors:  Weijia Zhang; Zhengzi Yi; Chengguo Wei; Karen L Keung; Zeguo Sun; Caixia Xi; Christopher Woytovich; Samira Farouk; Lorenzo Gallon; Madhav C Menon; Ciara Magee; Nader Najafian; Milagros D Samaniego; Arjang Djamali; Stephen I Alexander; Ivy A Rosales; Rex Neal Smith; Philip J O'Connell; Robert Colvin; Paolo Cravedi; Barbara Murphy
Journal:  JCI Insight       Date:  2019-06-06

6.  Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus.

Authors:  K Hudspeth; S Wang; J Wang; S Rahman; M A Smith; K A Casey; Z Manna; M Sanjuan; R Kolbeck; S Hasni; R Ettinger; R M Siegel
Journal:  Clin Exp Immunol       Date:  2019-03-19       Impact factor: 4.330

7.  Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus.

Authors:  Zhan Huang; Binqing Fu; Song Guo Zheng; Xiaomei Li; Rui Sun; Zhigang Tian; Haiming Wei
Journal:  J Immunol       Date:  2011-02-04       Impact factor: 5.422

8.  Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus.

Authors:  Elisaveta N Voynova; Jeffrey Skinner; Silvia Bolland
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

9.  Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients.

Authors:  Yi-Lung Lin; Shih-Chang Lin
Journal:  Clin Exp Med       Date:  2015-11-21       Impact factor: 3.984

10.  NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.

Authors:  Ana Henriques; Luís Teixeira; Luís Inês; Tiago Carvalheiro; Ana Gonçalves; António Martinho; Maria Luísa Pais; José António Pereira da Silva; Artur Paiva
Journal:  Clin Rheumatol       Date:  2013-02-02       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.